Search
for

    Research

    5 / 1000+ results

      research Cutaneous manifestations associated with substance use disorders

      April 2025 in “JAAD reviews.”
      This review provides an overview of skin manifestations associated with substance use disorder but reports no new clinical findings; the authors emphasize the importance of dermatological evaluation and multidisciplinary care in managing these cases.
      Characteristics of 60 Adult Chronic Hair Pullers

      research Characteristics of 60 adult chronic hair pullers

      417 citations , March 1991 in “American Journal of Psychiatry”
      This study found that adult trichotillomania is a chronic disorder often linked with high psychiatric comorbidity and suggests the tension-reduction criterion in diagnoses might be too restrictive.
      Sex Differences in Opioid-Mediated Effects: Role of Androgens

      research Sex Differences in Opioid-Mediated Effects: Role of Androgens

      October 2020 in “Authorea (Authorea)”
      This review discusses the influence of androgens on opioid-mediated effects and calls for further research into their role in sex differences and potential therapeutic options for chronic pain and substance use disorders.
      Dermatologic Signs and Symptoms of Substance Abuse

      research Dermatologic Signs and Symptoms of Substance Abuse

      11 citations , January 2016 in “Journal of clinical & experimental dermatology research”
      This review discusses the cutaneous manifestations associated with various substances of abuse, highlighting their importance for clinicians in recognizing and treating substance abuse disorders, and reports no new findings.

    Community Join

    5 / 319 results

    Learn

    2 / 801 results

      learn Neem Oil

      natural substance from Neem tree with medicinal and pesticidal properties

      learn GHK-Cu

      • GHK-Cu: Does it have side effects or is it completely safe? For topical cosmetic use, the small laboratory evidence base found GHK-Cu non-irritating, and reported reactions are local and uncommon; for injected or oral use there is effectively no human safety data, and the FDA lists GHK-Cu among bulk substances that may present significant safety risks in compounding.